Loading insider details...
Beta
Latest Form 4 (Jul 23, 2026): Grant/Award of 8,251 VRTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 23, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 8,251 | n/a |
| Jul 7, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 1,500 | $787.5K |
| May 12, 2026 | Odyssey Therapeutics, Inc. (ODTX) | Grant/Award | 27,393 | n/a |
| Feb 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 1,627 | $789.3K |
| Feb 19, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 5,789 | n/a |
| Feb 18, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 3,804 | $1.86M |
| Feb 12, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 2,140 | $1.00M |
| Jan 26, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 7,866 | n/a |
| Jan 9, 2026 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 4,500 | $2.14M |
| Dec 5, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 4,500 | $2.02M |